• Contact

  • Newsletter

  • About us

  • Delivery options

  • Prospero Book Market Podcast

  • Purinergic Receptors and their Modulators

    Purinergic Receptors and their Modulators by Colotta, Vittoria; Supuran, Claudiu T.;

    Series: Topics in Medicinal Chemistry; 41;

      • GET 20% OFF

      • The discount is only available for 'Alert of Favourite Topics' newsletter recipients.
      • Publisher's listprice EUR 320.99
      • The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.

        133 130 Ft (126 791 Ft + 5% VAT)
      • Discount 20% (cc. 26 626 Ft off)
      • Discounted price 106 504 Ft (101 433 Ft + 5% VAT)

    133 130 Ft

    db

    Availability

    printed on demand

    Why don't you give exact delivery time?

    Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.

    Product details:

    • Edition number 2023
    • Publisher Springer International Publishing
    • Date of Publication 29 September 2023
    • Number of Volumes 1 pieces, Book

    • ISBN 9783031397240
    • Binding Hardback
    • No. of pages354 pages
    • Size 235x155 mm
    • Weight 711 g
    • Language English
    • Illustrations X, 354 p.
    • 491

    Categories

    Long description:

    This book overviews purinergic receptors that are playing key roles in human and pathophysiological processes. The book elaborates on how selective P1 and P2 modulators have been developed as therapeutics for a variety of diseases. It also provides an overview of current perspectives in the design of purinergic receptor modulators and future challenges such as the availability of selective ligands for all receptor subtypes.

    Divided into 12 chapters, this comprehensive volume also offers a multidisciplinary perspective on the historical evolution, starting with a chapter devoted to the roots and early discoveries of adenosine and its receptors, followed by a twenty-year retrospective on the synthesis, properties, and functional potential of adenosine receptor ligands, probes, and functional conjugates. In the next chapters, experts in the field delve into topics such as the therapeutic potential of adenosine receptor ligands in wound healing and fibrosis, the therapeutic benefits of A2A receptor antagonists, the A2B adenosine receptor as a target for brain ischemia or demyelination, the development and latest advancements in clinical trials of A3 adenosine receptor ligands. Other chapters describe bifunctional tools to study adenosine receptors, allosteric modulators of adenosine receptors, and new computational approaches to inspect adenosine receptor-ligand recognition processes. Furthermore, the book discusses the role of P2X4 receptors in immunity and inflammation. The final chapters illustrate CD73 inhibitors as antitumor agents, and bacterial ectonucleotidases as underexplored antibacterial drug targets.

    This book is a valuable resource for scholars working in the field of medicinal chemistry, as well as researchers in the industry, providing readers with a comprehensive understanding of adenosine receptor biology and its therapeutic potential.

    More

    Table of Contents:

    Once upon a time adenosine and its receptors. Historical survey and perspectives as potential targets for therapy in human diseases.- Adenosine receptor ligands, probes and functional conjugates: A twenty-year history of pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines (PTP).- Adenosine receptor ligands as potential therapeutic agents for impaired wound healing and fibrosis.- Adenosine A2A receptor antagonists: chemistry, SARs, modeling studies and therapeutic potential.- A2B Adenosine Receptor as a new and attractive target to treat brain ischemia or demyelination.- A3 adenosine receptor ligands: from discovery to clinical trials.- Bifunctional tools to study adenosine receptors.- Allosteric modulators of adenosine receptors.- New computational approaches in inspecting adenosine receptor-ligand recognition process.- P2X4 receptors in immunity and inflammation.- CD73 inhibitors as antitumor agents.- Bacterial ectonucleotidases- underexplored antibacterial targets.

    More
    Recently viewed
    previous
    Purinergic Receptors and their Modulators

    Utopia – A Norton Critical Edition

    More, Thomas; Logan, George M.; Adams, Robert M.;

    6 205 HUF

    5 895 HUF

    20% %discount
    Purinergic Receptors and their Modulators

    Signal Analysis of Hindustani Classical Music

    Datta, Asoke Kumar; Solanki, Sandeep Singh; Sengupta, Ranjan;

    62 125 HUF

    49 700 HUF

    20% %discount
    Purinergic Receptors and their Modulators

    AIDS and Business

    Faulk, Saskia; Usunier, Jean-Claude;

    83 606 HUF

    66 885 HUF

    20% %discount
    Purinergic Receptors and their Modulators

    Purinergic Receptors and their Modulators

    Colotta, Vittoria; Supuran, Claudiu T.

    133 130 HUF

    106 504 HUF

    Purinergic Receptors and their Modulators

    Close to Home Day-To-Day Calendar

    McPherson, John

    5 272 HUF

    4 850 HUF

    20% %discount
    Purinergic Receptors and their Modulators

    Selbstverständlich digital

    Joisten, Karen

    37 323 HUF

    29 859 HUF

    Purinergic Receptors and their Modulators

    Maxwell on Molecules and Gases

    Maxwell, James Clerk; Garber, Elizabeth; Brush, Stephen G.;

    37 264 HUF

    33 538 HUF

    20% %discount
    Purinergic Receptors and their Modulators

    The Organization of Information

    Joudrey, Daniel N.; Taylor, Arlene G.

    23 882 HUF

    19 106 HUF

    Purinergic Receptors and their Modulators

    Kermit

    Sabella, Kaysie L.;Edwards, Betty, Edwards, Kenneth(ed.)

    8 790 HUF

    8 086 HUF

    next